Overview

Study in Healthy Volunteers to Prove That 2 Rotigotine Patches From Different Manufacturing Processes Deliver Equivalent Drug Amount to the Body.

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The major aim of this study is to investigate and compare the drug amount delivered to the body after sequential application of 2 rotigotine transdermal patches from 2 different manufacturing processes.

Phase:

Phase 1

Details

Lead Sponsor:

UCB Pharma

Treatments:

N 0437
Rotigotine